Luminal conversion and immunoregulation by probiotics

Frontiers in Pharmacology

Volumn 6, Issue NOV, 2015, Pages

  Ganesh, Bhanu Priya ^a,b   Versalovic, James ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Commensal bacteria; Diet; Dietary compounds; Immunomodulation; Metabolites; Microbiome; Probiotics

Indexed keywords

4 AMINOBUTYRIC ACID; HISTAMINE; PROBIOTIC AGENT; SEROTONIN;

ADAPTIVE IMMUNITY; BACTEROIDETES; COMMENSAL; CROHN DISEASE; ERYSIPELATOCLOSTRIDIUM RAMOSUM; FECES MICROFLORA; HOMEOSTASIS; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; INNATE IMMUNITY; INTESTINE FLORA; METABOLITE; METAGENOMICS; MICROBIAL DIVERSITY; MICROORGANISM; NUTRIENT; REVIEW; ULCERATIVE COLITIS;

EID: 84951560134     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2015.00269     Document Type: Review

References (108)

1. Arena, M. P., Russo, P., Capozzi, V., Lopez, P., Fiocco, D., and Spano, G. (2014). Probiotic abilities of riboflavin-overproducing Lactobacillus strains: a novel promising application of probiotics. Appl. Microbiol. Biotechnol. 98, 7569-7581. doi: 10.1007/s00253-014-5837-x
2. Astbury, S. M., and Corfe, B. M. (2012). Uptake and metabolism of the short-chain fatty acid butyrate, a critical review of the literature. Curr. Drug Metab. 13, 815-821. doi: 10.2174/138920012800840428
3. Awaisheh, S. S., Al-Nabulsi, A. A., Osaili, T. M., Ibrahim, S., and Holley, R. (2013). Inhibition of Cronobacter sakazakii by heat labile bacteriocins produced by probiotic LAB isolated from healthy infants. J. Food Sci. 78, M1416-M1420. doi: 10.1111/1750-3841.12209
4. Ayabe, T., Ashida, T., Kohgo, Y., and Kono, T. (2004). The role of Paneth cells and their antimicrobial peptides in innate host defense. Trends Microbiol. 12, 394-398. doi: 10.1016/j.tim.2004.06.007
5. Backhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., and Gordon, J. I. (2005). Host-bacterial mutualism in the human intestine. Science 307, 1915-1920. doi: 10.1126/science.1104816
6. Baumgart, M., Dogan, B., Rishniw, M., Weitzman, G., Bosworth, B., Yantiss, R., et al. (2007). Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum. ISME J. 1, 403-418. doi: 10.1038/ismej.2007.52
7. Becker, N., Kunath, J., Loh, G., and Blaut, M. (2011). Human intestinal microbiota: characterization of a simplified and stable gnotobiotic rat model. Gut Microbes 2, 25-33. doi: 10.4161/gmic.2.1.14651
8. Berkes, J., Viswanathan, V. K., Savkovic, S. D., and Hecht, G. (2003). Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut 52, 439-451. doi: 10.1136/gut.52.3.439
9. Berni Canani, R., Sangwan, N., Stefka, A. T., Nocerino, R., Paparo, L., Aitoro, R., et al. (2015). Lactobacillus rhamnosus GG-supplemented formula expands butyrate-producing bacterial strains in food allergic infants. ISME J. 1-9. doi: 10.1038/ismej.2015.151 [Epub ahead of print].
10. Best, J., Nijhout, H. F., and Reed, M. (2010). Serotonin synthesis, release and reuptake in terminals: a mathematical model. Theor. Biol. Med. Model. 7, 34. doi: 10.1186/1742-4682-7-34
11. Birt, D. F., Hendrich, S., and Wang, W. (2001). Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol. Ther. 90, 157-177. doi: 10.1016/S0163-7258(01)00137-1
12. Blaut, M. (2013). Ecology and physiology of the intestinal tract. Curr. Top. Microbiol. Immunol. 358, 247-272. doi: 10.1007/82_2011_192
13. Blum, S., Haller, D., Pfeifer, A., and Schiffrin, E. J. (2002). Probiotics and immune response. Clin. Rev. Allergy Immunol. 22, 287-309. doi: 10.1385/CRIAI:22:3:287
14. Borchers, A. T., Selmi, C., Meyers, F. J., Keen, C. L., and Gershwin, M. E. (2009). Probiotics and immunity. J. Gastroenterol. 44, 26-46. doi: 10.1007/s00535-008-2296-0
15. Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., et al. (2011). Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc. Natl. Acad. Sci. U.S.A. 108, 16050-16055. doi: 10.1073/pnas.1102999108
16. Brestoff, J. R., and Artis, D. (2013). Commensal bacteria at the interface of host metabolism and the immune system. Nat. Immunol. 14, 676-684. doi: 10.1038/ni.2640
17. Budnowski, J., Hanschen, F. S., Lehmann, C., Haack, M., Brigelius-Flohe, R., Kroh, L. W., et al. (2013). A derivatization method for the simultaneous detection of glucosinolates and isothiocyanates in biological samples. Anal. Biochem. 441, 199-207. doi: 10.1016/j.ab.2013.07.002
18. Cain, A. M., and Karpa, K. D. (2011). Clinical utility of probiotics in inflammatory bowel disease. Altern. Ther. Health Med. 17, 72-79.
19. Cani, P. D., Everard, A., and Duparc, T. (2013). Gut microbiota, enteroendocrine functions and metabolism. Curr. Opin. Pharmacol. 13, 935-940. doi: 10.1016/j.coph.2013.09.008
20. Cario, E., and Podolsky, D. K. (2005). Intestinal epithelial TOLLerance versus inTOLLerance of commensals. Mol. Immunol. 42, 887-893. doi: 10.1016/j.molimm.2004.12.002
21. Chang, Y. C., and Nair, M. G. (1995). Metabolism of daidzein and genistein by intestinal bacteria. J. Nat. Prod. 58, 1892-1896. doi: 10.1021/np50126a014
22. Chassaing, B., Koren, O., Carvalho, F. A., Ley, R. E., and Gewirtz, A. T. (2014). AIEC pathobiont instigates chronic colitis in susceptible hosts by altering microbiota composition. Gut 63, 1069-1080. doi: 10.1136/gutjnl-2013-304909
23. Corfield, A. P., Myerscough, N., Longman, R., Sylvester, P., Arul, S., and Pignatelli, M. (2000). Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease. Gut 47, 589-594. doi: 10.1136/gut.47.4.589
24. Corfield, A. P., Wagner, S. A., Clamp, J. R., Kriaris, M. S., and Hoskins, L. C. (1992). Mucin degradation in the human colon-production of sialidase, sialate O-acetylesterase, N-acetylneuraminate lyase, arylesterase, and glycosulfatase activities by strains of fecal bacteria. Infect. Immun. 60, 3971-3978.
25. Corr, S. C., Li, Y., Riedel, C. U., O'Toole, P. W., Hill, C., and Gahan, C. G. (2007). Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc. Natl. Acad. Sci. U.S.A. 104, 7617-7621. doi: 10.1073/pnas.0700440104
26. Cummings, J. H., and Macfarlane, G. T. (1997). Role of intestinal bacteria in nutrient metabolism. JPEN J. Parenter. Enteral Nutr. 21, 357-365. doi: 10.1177/0148607197021006357
27. Dao, M. C., Everard, A., Aron-Wisnewsky, J., Sokolovska, N., Prifti, E., Verger, E. O., et al. (2015). Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut doi: 10.1136/gutjnl-2014-308778 [Epub ahead of print].
28. de Jong, E. C., Vieira, P. L., Kalinski, P., Schuitemaker, J. H., Tanaka, Y., Wierenga, E. A., et al. (2002). Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse Th cell-polarizing signals. J. Immunol. 168, 1704-1709. doi: 10.4049/jimmunol.168.4.1704
29. Desbonnet, L., Garrett, L., Clarke, G., Bienenstock, J., and Dinan, T. G. (2008). The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. J. Psychiatr. Res. 43, 164-174. doi: 10.1016/j.jpsychires.2008.03.009
30. Desbonnet, L., Garrett, L., Clarke, G., Kiely, B., Cryan, J. F., and Dinan, T. G. (2010). Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 170, 1179-1188. doi: 10.1016/j.neuroscience.2010.08.005
31. Diaz Heijtz, R., Wang, S., Anuar, F., Qian, Y., Bjorkholm, B., Samuelsson, A., et al. (2011). Normal gut microbiota modulates brain development and behavior. Proc. Natl. Acad. Sci. U.S.A. 108, 3047-3052. doi: 10.1073/pnas.1010529108
32. Dylag, K., Hubalewska-Mazgaj, M., Surmiak, M., Szmyd, J., and Brzozowski, T. (2014). Probiotics in the mechanism of protection against gut inflammation and therapy of gastrointestinal disorders. Curr. Pharm. Des. 20, 1149-1155. doi: 10.2174/13816128113199990422
33. Elfoul, L., Rabot, S., Khelifa, N., Quinsac, A., Duguay, A., and Rimbault, A. (2001). Formation of allyl isothiocyanate from sinigrin in the digestive tract of rats monoassociated with a human colonic strain of Bacteroides thetaiotaomicron. FEMS Microbiol. Lett. 197, 99-103. doi: 10.1111/j.1574-6968.2001.tb10589.x
34. Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., et al. (2013). Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. U.S.A. 110, 9066-9071. doi: 10.1073/pnas.1219451110
35. Everard, A., and Cani, P. D. (2013). Diabetes, obesity and gut microbiota. Best Pract. Res. Clin. Gastroenterol. 27, 73-83. doi: 10.1016/j.bpg.2013.03.007
36. Fayol-Messaoudi, D., Berger, C. N., Coconnier-Polter, M. H., Lievin-Le Moal, V., and Servin, A. L. (2005). pH-, Lactic acid-, and non-lactic acid-dependent activities of probiotic Lactobacilli against Salmonella enterica Serovar Typhimurium. Appl. Environ. Microbiol. 71, 6008-6013. doi: 10.1128/AEM.71.10.6008-6013.2005
37. Feng, T., Wang, L., Schoeb, T. R., Elson, C. O., and Cong, Y. (2010). Microbiota innate stimulation is a prerequisite for T cell spontaneous proliferation and induction of experimental colitis. J. Exp. Med. 207, 1321-1332. doi: 10.1084/jem.20092253
38. Ferreira, C. M., Vieira, A. T., Vinolo, M. A., Oliveira, F. A., Curi, R., and Martins Fdos, S. (2014). The central role of the gut microbiota in chronic inflammatory diseases. J. Immunol. Res. 2014, 689492. doi: 10.1155/2014/689492
39. Fitzpatrick, L. R. (2013). Probiotics for the treatment of Clostridium difficile associated disease. World J. Gastrointest. Pathophysiol. 4, 47-52. doi: 10.4291/wjgp.v4.i3.47
40. Fleissner, C. K., Huebel, N., Abd El-Bary, M. M., Loh, G., Klaus, S., and Blaut, M. (2010). Absence of intestinal microbiota does not protect mice from diet-induced obesity. Br. J. Nutr. 104, 919-929. doi: 10.1017/S0007114510001303
41. Frank, D. N., St Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., and Pace, N. R. (2007). Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. U.S.A. 104, 13780-13785. doi: 10.1073/pnas.0706625104
42. Fung, K. Y., Cosgrove, L., Lockett, T., Head, R., and Topping, D. L. (2012). A review of the potential mechanisms for the lowering of colorectal oncogenesis by butyrate. Br. J. Nutr. 108, 820-831. doi: 10.1017/S0007114512001948
43. Galdeano, C. M., Nuñez, I. N., Carmuega, E., de LeBlanc, A. D., and Perdigón, G. (2015). Role of probiotics and functional foods in health: gut immune stimulation by two probiotic strains and a potential probiotic yoghurt. Endocr. Metab. Immune Disord. Drug Targets 15, 37-45.
44. Ganesh, B. P., Klopfleisch, R., Loh, G., and Blaut, M. (2013). Commensal Akkermansia muciniphila exacerbates gut inflammation in Salmonella Typhimurium-infected gnotobiotic mice. PLoS ONE 8:e74963. doi: 10.1371/journal.pone.0074963
45. Ganesh, B. P., Richter, J. F., Blaut, M., and Loh, G. (2012). Enterococcus faecium NCIMB 10415 does not protect interleukin-10 knock-out mice from chronic gut inflammation. Benef. Microbes 3, 43-50. doi: 10.3920/BM2011.0050
46. Geller, S. E., and Studee, L. (2006). Soy and red clover for mid-life and aging. Climacteric 9, 245-263. doi: 10.1080/13697130600736934
47. Hemarajata, P., Gao, C., Pflughoeft, K. J., Thomas, C. M., Saulnier, D. M., Spinler, J. K., et al. (2013). Lactobacillus reuteri-specific immunoregulatory gene rsiR modulates histamine production and immunomodulation by Lactobacillus reuteri. J. Bacteriol. 195, 5567-5576. doi: 10.1128/JB.00261-13
48. Hemarajata, P., and Versalovic, J. (2013). Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Therap. Adv. Gastroenterol. 6, 39-51. doi: 10.1177/1756283X12459294
49. Hooper, L. V., Stappenbeck, T. S., Hong, C. V., and Gordon, J. I. (2003). Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat. Immunol. 4, 269-273. doi: 10.1038/ni888
50. Hormannsperger, G., Clavel, T., Hoffmann, M., Reiff, C., Kelly, D., Loh, G., et al. (2009). Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria: impact on chronic inflammation. PLoS ONE 4:e4365. doi: 10.1371/journal.pone.0004365
51. Isolauri, E., Rautava, S., and Salminen, S. (2012). Probiotics in the development and treatment of allergic disease. Gastroenterol. Clin. North Am. 41, 747-762. doi: 10.1016/j.gtc.2012.08.007
52. Jeon, S. G., Kayama, H., Ueda, Y., Takahashi, T., Asahara, T., Tsuji, H., et al. (2012). Probiotic Bifidobacterium breve induces IL-10-producing Tr1 cells in the colon. PLoS Pathog. 8:e1002714. doi: 10.1371/journal.ppat.1002714
53. Kaplan, M. H., Wurster, A. L., and Grusby, M. J. (1998). A signal transducer and activator of transcription (Stat)4-independent pathway for the development of T helper type 1 cells. J. Exp. Med. 188, 1191-1196. doi: 10.1084/jem.188.6.1191
54. Ki, Y., Kim, W., Cho, H., Ahn, K., Choi, Y., and Kim, D. (2014). The effect of probiotics for preventing radiation-induced morphological changes in intestinal mucosa of rats. J. Korean Med. Sci. 29, 1372-1378. doi: 10.3346/jkms.2014.29.10.1372
55. Kim, S. C., Tonkonogy, S. L., Karrasch, T., Jobin, C., and Sartor, R. B. (2007). Dual-association of gnotobiotic IL-10-/-mice with 2 nonpathogenic commensal bacteria induces aggressive pancolitis. Inflamm. Bowel Dis. 13, 1457-1466. doi: 10.1002/ibd.20246
56. Klaenhammer, T. R., Kleerebezem, M., Kopp, M. V., and Rescigno, M. (2012). The impact of probiotics and prebiotics on the immune system. Nat. Rev. Immunol. 12, 728-734. doi: 10.1038/nri3312
57. Kotlowski, R., Bernstein, C. N., Sepehri, S., and Krause, D. O. (2007). High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease. Gut 56, 669-675. doi: 10.1136/gut.2006.099796
58. Krul, C., Humblot, C., Philippe, C., Vermeulen, M., van Nuenen, M., Havenaar, R., et al. (2002). Metabolism of sinigrin (2-propenyl glucosinolate) by the human colonic microflora in a dynamic in vitro large-intestinal model. Carcinogenesis 23, 1009-1016. doi: 10.1093/carcin/23.6.1009
59. Lepri, S. R., Zanelatto, L. C., da Silva, P. B., Sartori, D., Ribeiro, L. R., and Mantovani, M. S. (2014). Effects of genistein and daidzein on cell proliferation kinetics in HT29 colon cancer cells: the expression of CTNNBIP1 (beta-catenin), APC (adenomatous polyposis coli) and BIRC5 (survivin). Hum. Cell 27, 78-84. doi: 10.1007/s13577-012-0051-6
60. Li, J., Jia, H., Cai, X., Zhong, H., Feng, Q., Sunagawa, S., et al. (2014). An integrated catalog of reference genes in the human gut microbiome. Nat. Biotechnol. 32, 834-841. doi: 10.1038/nbt.2942
61. Lippmann, D., Lehmann, C., Florian, S., Barknowitz, G., Haack, M., Mewis, I., et al. (2014). Glucosinolates from pak choi and broccoli induce enzymes and inhibit inflammation and colon cancer differently. Food Funct. 5, 1073-1081. doi: 10.1039/c3fo60676g
62. Louis, P., Hold, G. L., and Flint, H. J. (2014). The gut microbiota, bacterial metabolites and colorectal cancer. Nat. Rev. Microbiol. 12, 661-672. doi: 10.1038/nrmicro3344
63. Ma, D., Forsythe, P., and Bienenstock, J. (2004). Live Lactobacillus reuteri is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression. Infect. Immun. 72, 5308-5314. doi: 10.1128/IAI.72.9.5308-5314.2004
64. Mabrok, H. B., Klopfleisch, R., Ghanem, K. Z., Clavel, T., Blaut, M., and Loh, G. (2012). Lignan transformation by gut bacteria lowers tumor burden in a gnotobiotic rat model of breast cancer. Carcinogenesis 33, 203-208. doi: 10.1093/carcin/bgr256
65. Mack, D. R., Michail, S., Wei, S., McDougall, L., and Hollingsworth, M. A. (1999). Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. Physiol. 276(4 Pt 1), G941-G950.
66. Matthews, G. M., Howarth, G. S., and Butler, R. N. (2012). Short-chain fatty acids induce apoptosis in colon cancer cells associated with changes to intracellular redox state and glucose metabolism. Chemotherapy 58, 102-109. doi: 10.1159/000335672
67. Matthies, A., Clavel, T., Gutschow, M., Engst, W., Haller, D., Blaut, M., et al. (2008). Conversion of daidzein and genistein by an anaerobic bacterium newly isolated from the mouse intestine. Appl. Environ. Microbiol. 74, 4847-4852. doi: 10.1128/AEM.00555-08
68. Matthies, A., Loh, G., Blaut, M., and Braune, A. (2012). Daidzein and genistein are converted to equol and 5-hydroxy-equol by human intestinal Slackia isoflavoniconvertens in gnotobiotic rats. J. Nutr. 142, 40-46. doi: 10.3945/jn.111.148247
69. McKenna, K., Beignon, A. S., and Bhardwaj, N. (2005). Plasmacytoid dendritic cells: linking innate and adaptive immunity. J. Virol. 79, 17-27. doi: 10.1128/JVI.79.1.17-27.2005
70. Morelli, L., and Capurso, L. (2012). FAO/WHO Guidelines on probiotics 10 years later FOREWORD. J. Clin. Gastroenterol. 46, S1-S2. doi: 10.1097/MCG.0b013e318269fdd5
71. Ochoa-Reparaz, J., Mielcarz, D. W., Ditrio, L. E., Burroughs, A. R., Foureau, D. M., Haque-Begum, S., et al. (2009). Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. J. Immunol. 183, 6041-6050. doi: 10.4049/jimmunol.0900747
72. Packey, C. D., and Sartor, R. B. (2009). Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases. Curr. Opin. Infect. Dis. 22, 292-301. doi: 10.1097/QCO.0b013e32832a8a5d
73. Peran, L., Camuesco, D., Comalada, M., Nieto, A., Concha, A., Adrio, J. L., et al. (2006). Lactobacillus fermentum, a probiotic capable to release glutathione, prevents colonic inflammation in the TNBS model of rat colitis. Int. J. Colorectal. Dis. 21, 737-746. doi: 10.1007/s00384-005-0773-y
74. Pflughoeft, K. J., and Versalovic, J. (2012). Human microbiome in health and disease. Annu. Rev. Pathol. 7, 99-122. doi: 10.1146/annurev-pathol-011811-132421
75. Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., et al. (2010). A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59-65. doi: 10.1038/nature08821
76. Rachmilewitz, D., Katakura, K., Karmeli, F., Hayashi, T., Reinus, C., Rudensky, B., et al. (2004). Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 126, 520-528. doi: 10.1053/j.gastro.2003.11.019
77. Rafii, F., Davis, C., Park, M., Heinze, T. M., and Beger, R. D. (2003). Variations in metabolism of the soy isoflavonoid daidzein by human intestinal microfloras from different individuals. Arch. Microbiol. 180, 11-16. doi: 10.1007/s00203-003-0551-6
78. Repa, A., Thanhaeuser, M., Endress, D., Weber, M., Kreissl, A., Binder, C., et al. (2014). Probiotics (Lactobacillus acidophilus and Bifidobacterium bifidum) prevent NEC in VLBW infants fed breast milk but not formula. Pediatr. Res. 77, 381-388. doi: 10.1038/pr.2014.192
79. Resta-Lenert, S., and Barrett, K. E. (2003). Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 52, 988-997. doi: 10.1136/gut.52.7.988
80. Roediger, W. E., Duncan, A., Kapaniris, O., and Millard, S. (1993). Reducing sulfur compounds of the colon impair colonocyte nutrition: implications for ulcerative colitis. Gastroenterology 104, 802-809.
81. Round, J. L., Lee, S. M., Li, J., Tran, G., Jabri, B., Chatila, T. A., et al. (2011). The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 332, 974-977. doi: 10.1126/science.1206095
82. Russell, R. M., Sharp, F. C., Rasko, D. A., and Sperandio, V. (2007). QseA and GrlR/GrlA regulation of the locus of enterocyte effacement genes in enterohemorrhagic Escherichia coli. J. Bacteriol. 189, 5387-5392. doi: 10.1128/JB.00553-07
83. Sah, B. N., Vasiljevic, T., McKechnie, S., and Donkor, O. N. (2014). Effect of probiotics on antioxidant and antimutagenic activities of crude peptide extract from yogurt. Food Chem. 156, 264-270. doi: 10.1016/j.foodchem.2014.01.105
84. Salazar, N., Dewulf, E. M., Neyrinck, A. M., Bindels, L. B., Cani, P. D., Mahillon, J., et al. (2014). Inulin-type fructans modulate intestinal Bifidobacterium species populations and decrease fecal short-chain fatty acids in obese women. Clin. Nutr. 34, 501-507. doi: 10.1016/j.clnu.2014.06.001
85. Sanders, M. E., Lenoir-Wijnkoop, I., Salminen, S., Merenstein, D. J., Gibson, G. R., Petschow, B. W., et al. (2014). Probiotics and prebiotics: prospects for public health and nutritional recommendations. Ann. N. Y. Acad. Sci. 1309, 19-29. doi: 10.1111/nyas.12377
86. Saulnier, D. M., Santos, F., Roos, S., Mistretta, T. A., Spinler, J. K., Molenaar, D., et al. (2011). Exploring metabolic pathway reconstruction and genome-wide expression profiling in Lactobacillus reuteri to define functional probiotic features. PLoS ONE 6:e18783. doi: 10.1371/journal.pone.0018783
87. Scalbert, A., Manach, C., Morand, C., Remesy, C., and Jimenez, L. (2005). Dietary polyphenols and the prevention of diseases. Crit. Rev. Food Sci. Nutr. 45, 287-306. doi: 10.1080/1040869059096
88. Sharma, R., Young, C., and Neu, J. (2010). Molecular modulation of intestinal epithelial barrier: contribution of microbiota. J. Biomed. Biotechnol. 2010, 305879. doi: 10.1155/2010/305879
89. Sherman, P. M., Ossa, J. C., and Johnson-Henry, K. (2009). Unraveling mechanisms of action of probiotics. Nutr. Clin. Pract. 24, 10-14. doi: 10.1177/0884533608329231
90. Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermudez-Humaran, L. G., Gratadoux, J. J., et al. (2008). Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. U.S.A. 105, 16731-16736. doi: 10.1073/pnas.0804812105
91. Swidsinski, A., Khilkin, M., Kerjaschki, D., Schreiber, S., Ortner, M., Weber, J., et al. (1998). Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology 115, 281-286. doi: 10.1016/S0016-5085(98)70194-5
92. Swidsinski, A., Loening-Baucke, V., Vaneechoutte, M., and Doerffel, Y. (2008). Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora. Inflamm. Bowel Dis. 14, 147-161. doi: 10.1002/ibd.20330
93. Thomas, C. M., Hong, T., van Pijkeren, J. P., Hemarajata, P., Trinh, D. V., Hu, W., et al. (2012). Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of PKA and ERK signaling. PLoS ONE 7:e31951. doi: 10.1371/journal.pone.0031951
94. Thomas, C. M., and Versalovic, J. (2010). Probiotics-host communication: modulation of signaling pathways in the intestine. Gut Microbes 1, 148-163. doi: 10.4161/gmic.1.3.11712
95. Ukena, S. N., Singh, A., Dringenberg, U., Engelhardt, R., Seidler, U., Hansen, W., et al. (2007). Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. PLoS ONE 2:e1308. doi: 10.1371/journal.pone.0001308
96. Ukibe, K., Miyoshi, M., and Kadooka, Y. (2015). Administration of Lactobacillus gasseri SBT2055 suppresses macrophage infiltration into adipose tissue in diet-induced obese mice. Br. J. Nutr. 114, 1180-1187. doi: 10.1017/S0007114515002627
97. Usui, T. (2006). Pharmaceutical prospects of phytoestrogens. Endocr. J. 53, 7-20. doi: 10.1507/endocrj.53.7
98. Valeur, N., Engel, P., Carbajal, N., Connolly, E., and Ladefoged, K. (2004). Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Appl. Environ. Microbiol. 70, 1176-1181. doi: 10.1128/AEM.70.2.1176-1181.2004
99. Veiga, P., Gallini, C. A., Beal, C., Michaud, M., Delaney, M. L., DuBois, A., et al. (2010). Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes. Proc. Natl. Acad. Sci. U.S.A. 107, 18132-18137. doi: 10.1073/pnas.1011737107
100. Vieira, A. T., Galvao, I., Amaral, F. A., Teixeira, M. M., Nicoli, J. R., and Martins, F. S. (2015). Oral treatment with Bifidobacterium longum 51A reduced inflammation in a murine experimental model of gout. Benef. Microbes doi: 10.3920/BM2015.0015 [Epub ahead of print].
101. Wang, F. Y., Liu, J. M., Luo, H. H., Liu, A. H., and Jiang, Y. (2015). Potential protective effects of Clostridium butyricum on experimental gastric ulcers in mice. World J. Gastroenterol. 21, 8340-8351. doi: 10.3748/wjg.v21.i27.8340
102. Weng, H., Endo, K., Li, J., Kito, N., and Iwai, N. (2015). Induction of peroxisomes by butyrate-producing probiotics. PLoS ONE 10:e0117851. doi: 10.1371/journal.pone.0117851
103. Wohlgemuth, S., Haller, D., Blaut, M., and Loh, G. (2009). Reduced microbial diversity and high numbers of one single Escherichia coli strain in the intestine of colitic mice. Environ. Microbiol. 11, 1562-1571. doi: 10.1111/j.1462-2920.2009.01883.x
104. Woting, A., Pfeiffer, N., Loh, G., Klaus, S., and Blaut, M. (2014). Clostridium ramosum promotes high-fat diet-induced obesity in gnotobiotic mouse models. mBio 5, e01530-14. doi: 10.1128/mBio.01530-14
105. Wu, H. J., Ivanov, I. I., Darce, J., Hattori, K., Shima, T., Umesaki, Y., et al. (2010a). Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 32, 815-827. doi: 10.1016/j.immuni.2010.06.001
106. Wu, X., Zhu, Y., Yan, H., Liu, B., Li, Y., Zhou, Q., et al. (2010b). Isothiocyanates induce oxidative stress and suppress the metastasis potential of human non-small cell lung cancer cells. BMC Cancer 10:269. doi: 10.1186/1471-2407-10-269
107. Yan, F., Cao, H., Cover, T. L., Whitehead, R., Washington, M. K., and Polk, D. B. (2007). Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 132, 562-575. doi: 10.1053/j.gastro.2006.11.022
108. Zakostelska, Z., Kverka, M., Klimesova, K., Rossmann, P., Mrazek, J., Kopecny, J., et al. (2011). Lysate of probiotic Lactobacillus casei DN-114 001 ameliorates colitis by strengthening the gut barrier function and changing the gut microenvironment. PLoS ONE 6:e27961. doi: 10.1371/journal.pone.0027961